MLC1501 Study Assessing Efficacy in STROke Recovery
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 540 participants.
Also called NCT05046106
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 540 participants
- Sponsor
- Moleac Pte Ltd.
- Registry
-
NCT05046106
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT05046106. Randomized; quadruple masking; primary purpose treatment. Start 2025-01 (anticipated); primary completion 2028-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- MLC1501 Study Assessing Efficacy in STROke Recovery
- Acronym
- MAEStro
- Condition
- Stroke
- Condition
- Stroke, Ischemic
- Condition
- Strokes Thrombotic
- Condition
- Stroke Sequelae
- Condition
- Stroke, Cardiovascular
- Condition
- Stroke, Embolic
- Condition
- Stroke, Cryptogenic
- Intervention (Drug)
- MLC1501
- Intervention (Other)
- Placebo
- Lead sponsor
- Moleac Pte Ltd.
Record details
- Record id
cardio:ct-nct05046106- Content hash
abeaab7b632e5517de980070dd683fe5004ed84e354a946da0f2dd18dc251e50